Oligometastatic Breast Cancer: A Shift from Palliative to Potentially Curative Treatment?
Open Access
- 1 February 2014
- journal article
- review article
- Published by S. Karger AG in Breast Care
- Vol. 9 (1), 7-14
- https://doi.org/10.1159/000358750
Abstract
A distinctive subset of metastatic breast cancer is represented by the so called ‘oligometastatic' disease, characterized by single/few detectable metastatic lesions. A more aggressive multidisciplinary approach can be considered in this patient population: available data report favorable results of ‘radical' local therapy for limited metastatic disease at least in a subset of selected patients. Selection bias and the retrospective nature of data do not allow for generalization of the results: the use of such approaches must be individualized and managed within a multidisciplinary team of dedicated specialists. Improvement in surgical and radiation techniques, development of new tools to deliver local chemotherapy, and new procedures (i.e. cryosurgery, laser and microwave ablation) mandate careful evaluation of such single and combined modalities in controlled clinical trials. A more accurate identification of patients with limited metastases and better definition of treatment endpoints will also allow correct patient selection for locally aggressive therapies. This paper focusses on local treatment of the primary tumor and of the most frequent distant disease sites in the presence of oligometastatic disease.This publication has 91 references indexed in Scilit:
- What Can Be Learnt about Disease Progression in Breast Cancer Dormancy from Relapse Data?PLOS ONE, 2013
- Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcomeSurgery, 2012
- The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastasesCancer, 2010
- The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineJournal of Neuro-Oncology, 2009
- Pulmonary metastases of breast cancer. When is resection indicated?European Journal of Cardio-Thoracic Surgery, 2008
- Breast Cancer Metastasis to the Central Nervous SystemThe American Journal of Pathology, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004